Friday, January 31, 2025
spot_img

Purchase of Own Securities and Total Voting Rights

Octopus AIM VCT 2 plc

Purchase of Own Securities and Total Voting Rights

Octopus AIM VCT 2 plc (the ‘Company’) announces that on 30 January 2025 the Company purchased for cancellation 802,694 ordinary shares of 0.01p each at a price of 38.38p per share.

Following this transaction, the issued share capital and total voting rights of the Company will be 202,277,913 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

Rachel Peat
Octopus Company Secretarial Services Limited
Tel: +44 (0)80 0316 2067

LEI: 213800BW27BKJCI35L17

Powered by SlickText.com

Hot this week

Edf: EDF announces the success of its green senior multi-tranche bond issue for a nominal amount of CAD 750 million

EDF announces the success of its green senior multi-tranche...

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN...

BW Energy: Fourth Quarter Results 2024

BW ENERGY FOURTH QUARTER RESULTS 2024 ...

Inbank Financial Calendar for 2025

AS Inbank has approved the company's Financial Calendar for...

VALLOUREC JOINS THE HYDROGEN COUNCIL

VALLOUREC JOINS THE HYDROGEN COUNCIL Meudon (France), January...

Topics

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN...

BW Energy: Fourth Quarter Results 2024

BW ENERGY FOURTH QUARTER RESULTS 2024 ...

Inbank Financial Calendar for 2025

AS Inbank has approved the company's Financial Calendar for...

VALLOUREC JOINS THE HYDROGEN COUNCIL

VALLOUREC JOINS THE HYDROGEN COUNCIL Meudon (France), January...

Scatec fourth quarter & full year 2024: Continued profitable growth

Oslo, 31 January 2025: In the fourth quarter, Scatec...

Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update

Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a...
spot_img

Related Articles

Popular Categories

spot_img